Literature DB >> 17328562

Cdc25 phosphatases: structure, specificity, and mechanism.

Johannes Rudolph1.   

Abstract

Cdc25 phosphatases, as activators of the Cdk/cyclins, play critical roles in the regulation of the eukaryotic cell cycle. Because of their overexpression and correlation with poor prognosis in many diverse cancers, Cdc25 phosphatases are attractive targets for anticancer drug development. Over the past few years, much knowledge of the basic enzymology of the Cdc25 phosphatases that may aid in the development of specific inhibitors has been gained. We review herein the structure, specificity, and mechanism of the Cdc25 phosphatases with a special focus on the activity of Cdc25 phosphatases with native protein substrates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17328562     DOI: 10.1021/bi700026j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  54 in total

1.  Toward the virtual screening of Cdc25A phosphatase inhibitors with the homology modeled protein structure.

Authors:  Hwangseo Park; Young Ho Jeon
Journal:  J Mol Model       Date:  2008-05-27       Impact factor: 1.810

Review 2.  The function of spliceosome components in open mitosis.

Authors:  Jennifer C Hofmann; Alma Husedzinovic; Oliver J Gruss
Journal:  Nucleus       Date:  2010-08-13       Impact factor: 4.197

Review 3.  Analysis of individual molecular events of DNA damage response by flow- and image-assisted cytometry.

Authors:  Zbigniew Darzynkiewicz; Frank Traganos; Hong Zhao; H Dorota Halicka; Joanna Skommer; Donald Wlodkowic
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

Review 4.  Small molecule tools for functional interrogation of protein tyrosine phosphatases.

Authors:  Rongjun He; Li-Fan Zeng; Yantao He; Sheng Zhang; Zhong-Yin Zhang
Journal:  FEBS J       Date:  2012-08-16       Impact factor: 5.542

Review 5.  Is Cdc25 a druggable target?

Authors:  John S Lazo; Peter Wipf
Journal:  Anticancer Agents Med Chem       Date:  2008-12       Impact factor: 2.505

Review 6.  In vivo roles of CDC25 phosphatases: biological insight into the anti-cancer therapeutic targets.

Authors:  Hiroaki Kiyokawa; Dipankar Ray
Journal:  Anticancer Agents Med Chem       Date:  2008-12       Impact factor: 2.505

Review 7.  An overview of stress response and hypometabolic strategies in Caenorhabditis elegans: conserved and contrasting signals with the mammalian system.

Authors:  Benjamin Lant; Kenneth B Storey
Journal:  Int J Biol Sci       Date:  2010-01-07       Impact factor: 6.580

Review 8.  Impaired DNA damage response--an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy.

Authors:  Zbigniew Darzynkiewicz; Frank Traganos; Donald Wlodkowic
Journal:  Eur J Pharmacol       Date:  2009-10-18       Impact factor: 4.432

Review 9.  Redox-directed cancer therapeutics: molecular mechanisms and opportunities.

Authors:  Georg T Wondrak
Journal:  Antioxid Redox Signal       Date:  2009-12       Impact factor: 8.401

Review 10.  Protein tyrosine phosphatases in glioma biology.

Authors:  Anna C Navis; Monique van den Eijnden; Jan T G Schepens; Rob Hooft van Huijsduijnen; Pieter Wesseling; Wiljan J A J Hendriks
Journal:  Acta Neuropathol       Date:  2009-11-21       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.